Notably, loss of either ASCL1 or OLIG2 had only modest effects on tumor progression and survival, likely due to redundant functions of these two transcription factors given their extensive shared binding in GBMs (Fig. 1). The gene discussed is ASCL1; the disease is neoplasm.